Skip to content
Whitehawk Therapeutics
  • About Us
    • Who We Are
    • Leadership
    • Board of Directors
  • Technology
  • Pipeline
    • Pipeline
    • HWK-007
    • HWK-016
    • HWK-206
  • Investors & News
  • Contact Us
LinkedIn icon
Whitehawk Therapeutics
  • About Us
    • Who We Are
    • Leadership
    • Board of Directors
  • Technology
  • Pipeline
    • Pipeline
    • HWK-007
    • HWK-016
    • HWK-206
  • Investors & News
  • Contact Us
LinkedIn icon

Contact Us

info@whitehawktx.com

IR@whitehawktx.com

(551) 321-2234

map marker icon

2 Headquarters Plaza, East Building, 11th Floor, Morristown, NJ, 07960

Careers

View All Open Positions

Contact Header

Recent News

September 13, 2026

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026

Read article

September 10, 2026

Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Read article

September 2, 2026

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Read article

VIEW ALL PRESS RELEASES

© Whitehawk Therapeutics, Inc. All rights reserved

  • Privacy Policy
  • Terms & Conditions
LinkedIn icon